SOURCE: Elsevier Business Solutions

March 09, 2010 11:26 ET

Medtech Deals Remain Attractive to VCs and Business-Development Execs at Elsevier Business Intelligence's 'IN3 West'

Nearly 200 Attendees and 40 Innovative Presenting Companies Along With a Dozen Sponsors Convened Last Week in Las Vegas

LAS VEGAS, NV--(Marketwire - March 9, 2010) -  Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted 'IN3 West' on March 4-5, 2010, at The Venetian Resort-Hotel-Casino, Las Vegas. This annual event followed 'Medical Device Investor Day', also held at The Venetian, on March 3rd, 2010.

The IN3 West conference included 12 sponsors and was attended by nearly 200 registered guests -- including venture capitalists and medtech business-development executives who learned about the latest innovations and investment opportunities from 40 emerging medical technology companies seeking funding and/or strategic partnerships.

"Dealmaking still remains a challenge, which is why forums such as IN3 are absolutely essential to figuring out the keys to successful funding," said David Cassak, Managing Director, Elsevier Business Intelligence.

"This conference afforded me the opportunity to meet not only with some of the major multinational companies but also several industry-savvy investors whom I would not likely have been able to meet otherwise," said Joseph W. Reilly, President and CEO of Soft Tissue Regeneration, one of the presenting companies. "This was my second IN3 event, and I am very impressed with the value that IN3 meetings offer emerging companies for the opportunity to get in front of top-shelf investors."

"Medmarc has been a proud sponsor of IN3 since its inception. We, with our strategic alliance partner, The Hartford, find that it is a good way to keep abreast of emerging technology. IN3 provides an excellent forum to stay in contact with existing customers as well as to develop prospective customers," added Tom Konopka, Senior Vice President of Business Development and Marketing for Medmarc Insurance.

Upcoming IN3 events in 2010 include: April 29-30: 'IN3 Europe', Paris, "Bridging European and U.S. Medical Device Innovators, Investors and Companies" (Marriott Rive Gauche Hotel); June 9-11: 'IN3 East', Boston, "Investment In Innovation (IN3) East + Investor Day -- The Largest East Coast Strategic Partnership and Investment Meeting for Medical Technology Executives" (The Westin Copley Place); Oct. 27-29: 'IN3 Summit', San Francisco, "Investment In Innovation (In3) Summit + Investor Day: The Largest Investment & Partnering Event for Medical Technology Leaders" (Grand Hyat).

For more information, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email

About Elsevier Business Intelligence

Elsevier Business Intelligence, an Elsevier company, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. Elsevier Business Intelligence ( has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct (, MDConsult (, Nursing Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact Information